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25-hydroxycholesterol in rat prostate
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Dehydroepiandrosterone (DHEA) is the most prominent circu-
lating steroid in humans, and it is a precursor for sex-steroid
synthesis in peripheral tissues, including the prostate. Recently,
enzyme-mediated pre-receptor metabolism has been recognized
as a key step in determining steroid action in io. Hydroxylation
of 3b-steroids at the 7a-position has been reported in rat and
human prostate to be a major inhibitory pathway to sex-steroid
synthesis}action. However, the molecular identity of the enzyme
responsible is so far unknown. We recently described a novel
cytochrome P450 enzyme, cyp7b1, strongly expressed in the
hippocampus of rodent brain, which catalyses the metabolism of
DHEA, pregnenolone and 25-hydroxycholesterol to 7a-hydroxy
products. In the light of this new enzyme, we have examined its
possible role in 7a-hydroxylation conversion in rat prostate.
NADPH-dependent 7a-hydroxylation was confirmed for 3b-
hydroxysteroids including DHEA and androstenediol, as well as
INTRODUCTION
Hyperplasia and subsequent neoplastic transformation of the
prostate gland constitutes a significant health risk, in particularly
in elderly males. Much research has been directed towards an
understanding of the factors governing cell proliferation in this
tissue. Growth, development and function of the prostate are
subject to hormonal control, in particular by androgens. In io,
steroids with androgenic activity originate primarily from two
sources : from the endocrine gonads via the circulation, and via
local synthesis in target tissues from the adrenal precursor
dehydroepiandrosterone (DHEA). DHEA and its sulphate ester
are the most abundant steroids in human blood [1], and together
they provide the substrates for testosterone and oestradiol
biosynthesis in accessory reproductive organs such as the mam-
mary gland and the prostate, and also in brain [2] (Scheme 1).
DHEA itself may have anti-glucocorticoid, neuroprotective and
immunoprotective properties [3–7]. Intriguingly, DHEA is also
reported to inhibit carcinogenesis in a variety of tissues, such as
mammary gland, skin, lung, liver and prostate [8–13]. However,
despite many studies suggesting that DHEA or related molecules
may have considerable therapeutic potential, the mechanism of
action of DHEA remains unclear, and no dedicated receptor has
yet been identified.
Local metabolism in target tissues is an important determinant
of steroid hormone action. A major pathway of DHEA metab-
olism is via hydroxylation, principally at the 7a position. Such
activity has been reported in the human, mouse and rat, and in
Abbreviations used: A/enedione, 4-androstene-3,17-dione; A/anediol, 5a-androstane-3b,17b-diol ; A/anetriol, 3b,7a,17b-androstanetriol ; A/enediol,
5-androstene-3b,17b-diol ; A/enetriol, 3b,7a,17b-androstenetriol ; cyp7a, cholesterol 7a-hydroxylase ; DHEA, dehydroepiandrosterone; E2, 17b-
oestradiol ; HOChol, hydroxycholesterol ; RT, reverse transcription. The term cyp7b1 is used in this paper to refer to mRNA and/or protein corresponding
to P450 cyp7b1, irrespective of the species of origin.
1 To whom correspondence should be addressed (e-mail cecile.martin!ed.ac.uk).
25-hydroxycholesterol. Kinetic analysis yielded an apparent K
m
of 14‡1 lM for 7a-hydroxylation of DHEA in the prostate
gland, a value similar to that recorded for recombinant cyp7b1
enzyme [13.6 lM; Rose, Stapleton, Dott, Kieny, Best, Schwarz,
Russell, Bjoorkheim, Seckl and Lathe (1997) Proc. Natl. Acad.
Sci. U.S.A. 94, 4925–4930]. The V
max
value of the prostate was
46‡2 pmol}min per mg, and this activity was inhibited by
clotrimazole, a P450-enzyme blocker. Moreover, RNA analysis
(reverse-transcription PCR, Northern blotting and in situ
hybridization) revealed a high expression of cyp7b1 mRNA in
the rat prostate, restricted to the epithelium, suggesting that
cyp7b1 catalyses oxysterol 7a-hydroxylation in the prostate
gland.
Key words: brain, cholesterol, cytochrome P450, epithelium.
a number of tissues and organs, such as skin, brain, prostate and
liver [14–17]. The enzyme(s) that are responsible for this in most
tissues are unknown. In liver, three different 7a-hydroxylation
pathways, each with distinct roles, are thought to regulate
cholesterol homoeostasis by producing 7a-hydroxylated bile
acids. In one pathway, cholesterol is converted by cholesterol 7a-
hydroxylase (cyp7a) into 7a-hydroxycholesterol (7a-HOChol)
[18–20]. cyp7a shows a marked preference for cholesterol, and is
not active against DHEA. In another pathway, cholesterol is first
converted into 24-HOChol before being 7a-hydroxylated by
cyp39A1 [21]. Both cyp7a and cyp39A1 are primarily expressed
in the liver, and appear to play primary roles in bile-acid
synthesis and cholesterol degradation.
We recently identified a new enzyme, cyp7b1, which is highly
expressed in brain, particularly in the hippocampus, but which is
also expressed in kidney and liver, although at a much lower level
[22,23]. cyp7b1 is a dual-acting steroid and sterol 7a-hydroxylase.
Whereas in the liver it appears to contribute to bile acid synthesis
via 7a-hydroxylation of HOChol [24,25], cyp7b1 (unlike cyp7a
and cyp39A1) is also active against circulating 3b-hydroxy-
steroids, including DHEA [23–25].
In the prostate, 7a-hydroxylation of 3b-hydroxysteroids has
also been described, but the enzyme responsible for the 7a-
hydroxylation of DHEA and related molecules has not been
identified [14,26,27]. In the present study, we used a combination
of RNA analysis [reverse-transcription (RT) with PCR, Northern
blotting and in situ hybridization] and biochemical techniques
to investigate the 7a-hydroxylase enzyme in rat prostate. We
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Scheme 1 Steroid pathway of DHEA
Abbreviations : 3b-HSD, 3b-hydroxysteroid dehydrogenase; 17b-HSD, 17b-hydroxysteroid
dehydrogenase. The asterisks show the steroid substrates for cyp7b1.
demonstrate that cyp7b1 mRNA is expressed in rat prostate, and
may be the predominant enzyme responsible for local steroid 7a-
hydroxylation. We discuss the possible role of cyp7b1 expression
in the prostate.
EXPERIMENTAL
Animals
Male Wistar rats (1 to 8 months old) were used for experiments.
Animals were killed by cervical dislocation. Brain, liver and
ventral prostate were rapidly removed and directly frozen in
liquid nitrogen. All tissues were stored at fi70 °C for the
subsequent preparation of RNA or protein extracts.
Steroids
[1,2,6,7-$H]DHEA (60 Ci}mmol), [9,11-$H]5a-androstane-
3b,17b-diol (A}anediol ; 50 Ci}mmol), [1,2-$H]3b,7a,17b-andro-
stenetriol (A}enediol; 42 Ci}mmol) and [26,27-$H]25-HOChol
(78.5 Ci}mmol) were purchased from NEN Life Science
Products, Boston, MA, U.S.A. [2,4,6,7,16,17-$H]17b-Oestradiol
(153 Ci}mmol) was purchased from Amersham Pharmacia
Biotech. (Little Chalfont, Bucks., U.K.). Non-radioactive
steroids and clotrimazole were obtained from Sigma–Aldrich
(Poole, Dorset, U.K.). 7a-Hydroxy-DHEA was purchased from
Steraloids Inc. (Wilton, NH, U.S.A.).
7a-Hydroxylase activity
7a-Hydroxylase activity was determined in homogenates of
pooled rat prostate. Rat brain and protein extracts from HeLa
cells transfected with recombinant cyp7b1 (vaccinia virus-
cyp7b1) were used as a positive control [23]. Liver, a tissue
expressing cyp7a, was included for comparison purposes. Frozen
tissue was homogenized in ice-cold PBS containing 20% (w}v)
glycerol, 0.25 M sucrose, 1 mM EDTA, 1 lg}ml pepstatin and
0.1 mM PMSF. The homogenate was centrifuged (4000 g, 5 min,
4 °C) and the supernatant was separated into aliquots and stored
at fi70 °C. Ethanol solutions of the radiolabelled steroid sub-
strates were dried under nitrogen in glass tubes. Substrate stock
solutions were diluted in ethanol or acetone}ethanol, and
reactions were performed using substrate concentrations in the
range of 5–20 lM, as described previously [23]. Incubations were
carried out in a total vol. of 1 ml. KPO
%
buffer (0.1 M, pH 7.4)
containing 1 mM EDTA was added, followed by the protein
extract; this was then mixed and incubated at 37 °C in a shaking
water bath. Reactions were started by addition of NADPH to a
final concentration of 1 mM. A 15 min incubation time was
employed within the linear part of the relationship between
product formation and time. Steroids were extracted with ethyl
acetate, dried and resuspended in 10 ll of ethyl acetate. Recovery
was typically around 90%. Reaction products were applied to
silica-gel TLC plates and developed in ethyl acetate}n-hexane}
acetic acid (16:8:1, by vol.). In this buffer, 7a-hydroxy-DHEA
and 7b-hydroxy-DHEA differ in terms of their migration on
TLC plates, with a mobility relative to DHEA of 0.32 and 0.5
for 7a-hydroxy-DHEA and 7b-hydroxy-DHEA respectively
[23]. Quantification of chromatograms was accomplished by
using a Phospho-Imager (FLA-2000; Fujifilm, Straubenhardt,
Germany). Initial reaction velocities were expressed in pmol}min
per mg of protein. Linear regression analysis was computed
using the ‘Sigma Plot ’ program and a double reciprocal plot
(Lineweaver–Burk) was used to determine V
max
and K
m
values.
Experiments were repeated three times.
HPLC analysis
A Waters HPLC system and an on-line scintillation counting
system (Berthold, Pforzheim, Germany) were used to verify the
identity of 7a-hydroxylated products of DHEA. The column
utilized was a reversed-phase C
")
column (Phenomenex,
Ho$ sbach, Germany) using a mobile phase [water}methanol}
acetonitrile (55:25:20, by vol.)]. This mobile phase gave retention
times for 7a-hydroxy-DHEA and DHEA of 7 and 24 min
respectively.
RNA extraction
Total RNA from the prostate gland was isolated as described
previously [28], resuspended in RNase-free water and stored at
fi70 °C. All the samples had intact 18 S and 28 S RNAs, as
assessed by ethidium bromide staining after agarose gel electro-
phoresis.
Oligonucleotide primers, RT and PCR amplification
5« and 3« primers for PCR (Oswel DNA Service, Southampton,
U.K.) were 5«-dGTTCAGCCGAAGATTATCAGCG-3« and
5«-dTCACGCAGGACTTCCATAGC-3«, corresponding to nt
54–75 and 655–674 of the rat cyp7b1 cDNA [22]. RT was
performed (in a reaction volume of 20 ll) in 10 mM Tris}HCl
(pH 9.0), 50 mM KCl, 2.5 mM MgCl
#
, 0.1% (w}v) Triton X-100,
1 mM each of dCTP, dGTP, dTTP and dATP, 10 units of
RNasin (Promega, Southampton, U.K.), 1–2 lg of total RNA,
12 units of avian myeloblastosis virus (‘AMV’) reverse trans-
criptase (Pharmacia, Milton Keynes, U.K.) and 0.1 nmol of 3«
PCR primer. Reactions were incubated for 10 min at room
temperature, followed by 30 min at 42 °C, then 95 °C for 5 min
(to inactivate the reverse transcriptase). Subsequent PCR ampli-
fication of specific cDNAs was achieved by transferring the RT
reaction to 80 ll of buffer containing 50 mM KCl, 10 mM
Tris}HCl (pH 9.0), 2.5 mM MgCl
#
, 0.2 mM each of dCTP,
dGTP, dTTP and dATP, 0.1 nmol of 5« PCR primer and 2.5 units
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of Taq polymerase (Promega). Following a ‘hot start ’ (5 min at
96 °C), samples were subjected to 30 cycles, as follows: 10 cycles
of 96 °C for 30 s, 50 °C for 1 min and 72 °C for 1 min, followed
by a further 20 cycles of 96 °C for 30 s, 55 °C for 1 min and 72 °C
for 1 min. A final extension step was carried out at 72 °C for
10 min. Amplified products were analysed by electrophoresis on
1% (w}v) agarose gels. The identity of the PCR product was
checked by restriction enzyme digestion using DraI and HinfI.
Cloning and sequencing of RT-PCR products
PCR products were subcloned into the vector pGEM-(T) easy
(Promega), which was then sequenced on both strands.
Northern blot analysis
RNA (20 lg) was size-fractionated by electrophoresis through a
1% (w}v) agarose gel in the presence of formaldehyde, followed
by capillary transfer to a nylon membrane and UV cross-linking.
Pre-hybridization was performed in pre-hybridization buffer
[0.13 M NaH
#
PO
%
}0.4 M Na
#
HPO
%
}3.3 mM EDTA}7% (w}v)
SDS}0.05 mg of denatured herring testes sperm DNA] for 2 h at
55 °C. The [$#P]P
i
-labelled cDNA probe, synthesized using a
random prime DNA-labelling kit (BoehringerMannheim, Mann-
heim, Germany), was added to the pre-hybridization buffer,
and hybridization (55 °C) was performed overnight. Blots were
washed twice with 1‹SSC buffer (0.15 M NaCl}0.015 M sodium
citrate)}0.1% (w}v) SDS for 20 min at room temperature, and
then once with 0.3‹SSC}0.1% (w}v) SDS for 20 min at 55 °C.
The membranes were subjected to autoradiography. The cDNA
template for the synthesis of the cyp7b1 probe was a 1.2 kb
cDNA fragment [22]. The loading control probe was 7 S cDNA
[29]. The ratio of cyp7b1 to 7 S RNA in the prostate was
arbitrarily set at 1.0 for prostate RNA from 1-month-old rats,
and results for older rat prostate RNA were expressed relative to
this.
cyp7b1 probe for in situ hydridization
A 700 bp EcoRI–PstI fragment of cyp7b1 cDNA was subcloned
into pGEM-3 (Promega) [22]. Linearized plasmid was used as a
template for SP6 or T7 RNA polymerase to generate the antisense
and sense RNA probes respectively. Probes were purified using
Nick columns (Sephadex G50 DNA grade; Amersham
Pharmacia, Uppsala, Sweden).
mRNA in situ hybridization
Cryostat sections (10 lm) from prostate glands of 3-month-old
adult rats were taken; sections from five different animals were
thaw-mounted on to 3-aminopropyltriethoxysilane-coated slides
and stored at fi80 °C. Fixing, hybridization (to 10( c.p.m.}ml
$&S-UTP-labelled cRNA probe at 50 °C for 14–16 h) and washing
were as described previously [30]. After RNase A treatment, the
slides were dehydrated, dried, placed against film (b-Max Hyper-
film; Amersham, Herts., U.K.), and stored at room temperature
for 2 days. Films were developed in D19 developer and fixed in
a 1:5 dilution of Amfix fixative. Non-specific hybridization was
determined by incubating adjacent sections with a $&S-UTP-
labelled sense probe under identical conditions. Following auto-
radiography, slides were first dipped in photographic emulsion,
and then counterstained with haematoxylin and eosin. Quanti-
fication was performed using a Seescan Imager (Seescan,
Cambridge, U.K.).
Statistics
Values shown are means‡S.E.M. Statistical comparisons (using
the ‘Sigma Stat ’ program) were made by analysis of variance
(‘ANOVA’) and the Rank Sum Test. Significance levels were set
at P! 0.05.
RESULTS
Rat prostate homogenate catalyses the production of 7a-hydroxy-
DHEA from DHEA
First, we examined extracts of rat prostate for 7a-hydroxylation
of DHEA, a preferred substrate for recombinant cyp7b1 in itro
[23]. NADPH-dependent 7a-hydroxylation of DHEA was clearly
detectable in extracts of this tissue. No products were obtained
in the absence of NADPH (results not shown). The rat prostate
homogenate generated a major product with a mobility on TLC
plates identical with that of the major product of recombinant
vaccinia virus-cyp7b1, which was also similar to the major rat
brain product [23] (Figure 1A). The unlabelled commercial
reference compound, 7a-hydroxy-DHEA, co-migrated in an
identical manner with the major product of prostatic DHEA,
A
B
Figure 1 Metabolism of DHEA in rat tissues
(A) TLC resolution of products generated by incubation of rat tissues homogenates with
[3H]DHEA. Lane markers : B (lanes 1 and 4), whole brain; L (lane 2), liver; P (lane 3), prostate.
Control with no membrane (D) is shown in lane 5. DHEA products generated by incubating
control vaccinia-transfected cell extracts (lane 6) or extract of cells infected by vaccinia virus
expressing cyp7b1 (lanes 7 and 8) are run in parallel for the tissue extracts. The horizontal
arrow indicates the origin of the gel. (B) HPLC profile of the radioactive spot removed from the
TLC plate showing a single peak at 7 min. The mobile phase was methanol/water/acetonitrile
(55 : 25 : 20, by vol.). The elution profile of the known reference compound was : 1, 7a-hydroxy-
DHEA; 2, A/enediol; 3, testosterone; 4, A/enedione; 5, DHEA; 6, 5a-dihydrotestosterone; 7, 3a-
5a-androstenediol; and 8, androsterone.
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Figure 2 Effect of clotrimazole on DHEA 7a-hydroxylation in the prostate
TLC of DHEA 7a-hydroxylation in rat prostate in the absence (lane 1) or in the presence of
1 lM (lane 2) or 10 lM (lane 3) clotrimazole.
Table 1 Catalytic properties of 7a-hydroxylation in prostatic homogenate
Each value represents the mean‡S.E.M. for three determinations.
Compound Vmax (pmol/min/mg) Km (lM)
A/enediol 97‡7 4‡0.2
25-HOChol 55‡3 1‡0.05
DHEA 46‡2 14‡1
E2 4‡1 11‡1
A/anediol 3‡2 22‡2
and was clearly distinct from 7b-hydroxy-DHEA, which migrates
differently under the same conditions [23]. The major metabolite
of DHEA, eluted from the TLC plates with ethyl acetate and
subjected to HPLC chromatographic analysis, emerged from the
column as a single peak at a retention time identical with that of
the commercial 7a-hydroxy-DHEA obtained by chemical syn-
thesis (Figure 1B). These data confirm that the major product
of DHEA is 7a-hydroxy-DHEA. The extent of the conversion of
[$H]DHEA into 7a-hydroxy-DHEA, normalized to protein con-
tent, was greater in rat prostate extracts than in total rat brain
homogenate. These data indicate that rat ventral prostate, like
recombinant cyp7b1, predominantly hydroxylates DHEA at the
7a position. Furthermore, the conversion of DHEA into 7a-
hydroxy-DHEA in the prostate was blocked, as reported for the
recombinant cyp7b1 enzyme [23], by the P450 inhibitor clo-
trimazole, at concentrations of 1–10 lM (Figure 2).
Kinetic parameters of 7a-hydroxylase activity in the prostate
gland : A/enediol, DHEA and 25-HOChol are the preferred
substrates
Kinetic characterization of the enzyme was performed in homo-
genates of pooled rat prostate glands. K
m
and V
max
values were
determined for DHEA, 17b-oestradiol (E
#
), A}anediol, A}
enediol and 25-HOChol. The substrate specificity of the enzyme
is summarized in Table 1. K
m
values obtained ranged from
1–22 lM (in order of decreasing K
m
, A}anediol"DHEA"
E
#
"A}enediol" 25-HOChol). The V
max
value for A}enediol
Figure 3 RT-PCR analysis of cyp7b1 mRNA in rat prostate
(A) RT-PCR was performed on total RNA from rat prostate (3 months old) (lane 1). No product
was detected in a PCR reaction lacking RNA (lane 2). RNA sample without reverse transcriptase
confirmed the absence of genomic DNA contamination (lane 3). (B) The identity of the PCR
product (620 bp) was checked by enzymic restriction with DraI (lane 4) and Hin fI (lane 5),
which cut the PCR product at 308 bp and 160 bp respectively. The nucleic-acid-size markers
are shown on the left of the gels (M).
Figure 4 Northern blot analysis of cyp7b1 expression in the rat prostate
Three different groups of animals were used for RNA extraction : 1-month-old (lanes 1–5), 3-
months-old (lanes 7–11) and 8-months-old (lanes 12–16) rats. RNA from each prostate was
resolved by gel electrophoresis, and the hybridization probe was a fragment of the rat cyp7b1
cDNA. cyp7b1 probe hybridized to two transcripts in the rat prostate at 1.8 and 2.1 kb. The
probe for the loading control corresponds to ribosomal protein 7 S.
was approximately twice that obtained for DHEA, and 30-fold
higher than that for A}anediol (3 pmol}min per mg protein; in
decreasing order of V
max
, A}enediol" 25-HOChol"DHEA"
E
#
" A}anediol). On the basis of catalytic-efficiency constants
(V
max
}K
m
) for this enzyme, 25-HOChol is the best substrate in
the prostate gland.
The effect of A}anediol and A}enediol on 7a-hydroxylation of
DHEA in prostate homogenate was examined. Unlabelled
steroids (2 and 10 lM) were co-incubated with 10 nM [$H]DHEA
under standard assay conditions. Both steroids inhibited the
formation of 7a-hydroxy-DHEA in a dose-dependent manner
(results not shown).
cyp7b1 mRNA is present in the prostate
To address whether the prostatic activity could be due to the
presence of the cyp7b1 enzyme, RT-PCR was performed on total
RNA from three different rat prostates. The amplified fragment
of 620 bp (Figure 3A) was cleavedwith DraI andHinfI, producing
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Figure 5 Distribution of cyp7b1 in rat prostate
High-resolution views of mRNA-encoding cyp7b1 distribution in rat prostate (A). Representative sense control sections are shown (B).
sub-fragments of 308 and 160 bp respectively, as expected for
cyp7b1 cDNA (Figure 3B). The PCR product was subcloned and
sequenced; the nucleotide sequence thus obtained was identical
with that previously reported for cyp7b1 from rat hippocampus
[22] (results not shown).
cyp7b1 mRNA in the rat prostate is differentially expressed with
aging
To examine the expression of cyp7b1 mRNA during postnatal
developmental of the rat prostate, we performed Northern blot
analysis on rat prostatic RNA obtained at three different ages (1,
3 and 8 months). The cyp7b1 cDNA probe identified two mRNA
transcripts corresponding in size to the cyp7b1 transcripts
reported previously in rat brain [22] (Figure 4). Some inter-
individual variability in the levels of cyp7b1 mRNA expression
was noted, which was not reflected in the intensity of the signal
obtained with the 7 S RNA loading control. Moreover, the
cyp7b1}7S mRNA ratio in the rat prostate appeared to decrease
with age: the ratio was 1.0‡0.2 at 1 month, 0.7‡0.2 at 3 months
and 0.6‡0.1 at 8 months; nevertheless, these differences have
failed to achieve statistical significance at the Pfl 0.05 level.
In situ hybridization analysis of cyp7b1 mRNA in the rat prostate
shows a high expression in the epithelium
To determine the site of cyp7b1 mRNA expression in the adult
rat prostate, in situ mRNA hybridization was performed on
cryosections of ventral prostate. cyp7b1 mRNA was restricted to
the epithelium, with no expression detected in the stroma (Figure
5A). Control sections hybridized to sense RNA probe revealed
only low background levels of hybridization (representative
sections are shown in Figure 5B); the level of cyp7b1 expression
was 15-fold greater than that of background (sense).
DISCUSSION
We present several lines of evidence to support the hypothesis
that oxysterol 7a-hydroxylase (cyp7b1) is expressed in the rat
prostate and is responsible for 7a-hydroxylation of steroids and
oxysterols.
We show that rat prostatic homogenates catalyse NADPH-
dependent hydroxylation of 3b-steroids such as DHEA, A}
enediol and 25-HOChol at the 7a position. Remarkably, in our
study, the best steroid substrate was A}enediol. A}enediol is
derived directly from DHEA by one of several 17b-hydroxy-
steroid dehydrogenases predominantly acting in the reductase
direction, and can itself be converted into testosterone by
widespread 3b-hydroxysteroid dehydrogenase activity. To aid
comparison of the substrates, we used only tritiated isotopes.
However, the apparent V
max
obtained with DHEA is almost
certainly an underestimate. [$H]DHEA is substituted at the 7a-
position, and it is known that the hydroxylation of tritium-
substituted sites is slower than that of unsubstituted sites.
However, the K
m
value obtained in our study is identical with the
one reported previously for the recombinant vaccinia virus-
Cyp7b protein using ["%C]DHEA (13.6 lM; [23]). 25-HOChol
also proved to be an effective substrate, with a catalytic efficiency
that was double than of A}enediol.
These kinetic parameters demonstrate clearly the presence of a
steroid 7a-hydroxylase activity in the prostate that catalyses the
7a-hydroxylation of A}enediol, DHEA, E
#
, A}anediol and 25-
HOChol. High concentrations of DHEA and A}enediol (6–7
times as high as plasma values) have been found in the human
prostate gland [31]. Moreover, the prostatic DHEA concen-
tration is 10-fold higher than the concentration of A}anediol in
the same tissue [31]. These data suggest that 3b-steroids, such as
DHEA and A}enediol (both substrates for cyp7b1), may
selectively accumulate in the prostate.
Previous studies have shown that only the novel brain-enriched
cytochrome P450 cyp7b1 exhibits both steroid and oxysterol 7a-
hydroxylase activity [23]. Other 7a-hydroxylases show different
substrate specificities : cyp7a is active against cholesterol and 24-
HOChol, but is largely inactive against steroids such as DHEA.
A second hepatic enzyme, cyp39A1, primarily metabolizes
HOChols [19,21]. Both cyp7a and cyp39A1 enzymes are
expressed predominantly, if not exclusively, in the liver. cyp7b1
is the only enzyme identified to date with the relevant substrate
preference and kinetic properties to account for the 7a-
hydroxylase activity in the prostate. Moreover, recent data show
that DHEA 7a-hydroxylation is dramatically reduced to baseline
levels in prostatic homogenates of mice homozygous for targeted
disruption of the cyp7b1 gene, suggesting that cyp7b1 is likely to
be the enzyme predominantly responsible for steroid 7a-hy-
droxylation in this tissue [31a]. However, this does not mean that
cyp7b1 is the sole enzyme with 7a-hydroxylase activity in the
prostate. An enzyme possessing 7a-hydroxylase activity has
previously been described in both rat and human prostates
# 2001 Biochemical Society
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[14,26,27], which appears to be specific for A}anediol and fails to
metabolize DHEA. Interestingly, DHEA and A}enediol can
inhibit the 7a-hydroxylation of A}anediol in the prostate [14].
Whereas this might reflect competition among substrates, these
data raise the possibility that additional enzymes with 7a-
hydroxylase activity may exist in the prostate, notably in species
other than mouse.
We report here that cyp7b1 mRNA is prominently expressed
in the rat prostate, and is exclusively expressed in the epithelium.
Although cyp7b1 was originally described as a brain-enriched
enzyme, expression was also detected in the liver and kidney [22].
Our more recently undertaken study performed in mouse has
suggested that cyp7b1 mRNA is quite widely expressed during
fetal development, including in the prostate, but the expression
becomes highly restricted in the immediate post-natal period
[32]. In another recent study, cyp7b1 mRNA was detected in a
variety of human tissues, particularly in tissues active in steroid
metabolism (testes, ovary, prostate, kidney and liver), but also in
tissues involved in bile-acid synthesis and absorption (liver, small
intestine, kidney and colon) [23,33]. Of course, the enzyme is
well-placed to determine the fate of DHEA in the epithelium,
and hence perhaps growth, during development and in adult life.
Finally, we found a considerable sample-to-sample variability
in cyp7b1 mRNA expression in the prostate, suggesting possible
regulation by factor(s) as yet unknown. Our data might allude to
the fact that there is a general decrease in mRNA expression
with age of the rat and}or the size of the prostate. A similar
relationship among prostate size, androgen levels and 7a-
hydroxylase activity has been reported previously [14,26]. Levels
of cyp7b1 mRNA and}or 7a-hydroxylase activity might directly
reflect the androgen status and}or the degree of cellular pro-
liferation in the prostate gland. Indeed, prostate development
and morphology are known to be dependent on androgen
regulation and the balance between cell proliferation and apop-
tosis.
What is the function of cyp7b1 in the prostate? One possibility,
suggested by the substrate preference of the enzyme, is that the
enzyme might protect against hyperplasia. DHEA stimulates cell
proliferation, and might serve either as a substrate for the local
synthesis of active androgens and}or oestrogens, or, possibly, by
facilitating androgen and oestrogen receptors by an unknown
mechanism [34–37]. A}enediol also appears to have intrinsic
oestrogenic and androgenic activity at physiological concen-
trations [1,38]. It is possible that, by metabolizing DHEA and
A}enediol, cyp7b1 could protect the prostate against sex-steroid-
induced proliferation and hyperplasia. In rat brain astrocytes,
which also metabolize DHEA and other neuroactive steroids to
androgens and oestrogens, 7a-hydroxylation is dependent upon
cell contact, such that a large degree of contact among cells shifts
steroid metabolism towards 7a-hydroxylated products at the
expense of the 3b-hydroxysteroid dehydrogenase oxidation path-
way to A}enedione [39]. It is possible that a similar mechanism
exists in the prostate, increasing the production of 7a-hydroxy-
sterols during the proliferative phase of the gland. This might
explain a rather controversial report that DHEA exhibits anti-
proliferative properties, inhibiting prostate carcinogenesis [40].
Moreover, some cyp7b1 products could act locally as active
steroids responsible for at least some of the effects ascribed to
DHEA and A}enediol.
In the liver, cyp7b1 catalyses the 7a-hydroxylation of 25- and
27-HOChol as a part of the process of the cholesterol degradative
pathway [24]. Although cholesterol metabolism has been studied
extensively in the liver, the prostate gland also contains high
levels of lipid [41]. Indeed, synthesis of cholesterol in the prostate
epithelium can be several times greater than that in the liver [42].
Furthermore, dramatic changes in feedback regulation of chol-
esterol synthesis have been noted in malignant tissues, including
prostatic adenoma (for a review, see [42]). Androgens, and, more
specifically, testosterone, appear to regulate cholesterogenesis
and, intriguingly, oxysterol 7a-hydroxylation, in the prostate, as
they also do in fibroblasts or liver [43].
In summary, we have demonstrated in the present study that
cyp7b1 mRNA is highly expressed in the epithelial cells of the
rat prostate, and is the enzyme responsible in both brain and
prostate for the 7a-hydroxylation of oxysterols. The function of
oxysterol metabolism in the prostate is still unknown and merits
further investigation.
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